“…Mice deficient of CCR6 or its ligand CCL20 have reduced skin inflammation in response to the IMQ stimulation ( Campbell et al., 2017 ; Cochez et al., 2017 ; Robert et al., 2017 ; Shi et al., 2021 ; Yu et al., 2019 ), suggesting that in contrast to the CCR10/CCL27 axis, the CCR6/CCL20 axis promotes the skin γδT17 cell activation and tissue inflammation. CCR4 is preferentially expressed in skin Th17 but not γδT17 cells and CCR4-deficient mice also have reduced skin inflammation in response to topical IMQ stimulation ( Matsuo et al., 2021 ). Corroborating with these mouse studies, clinical observations found that expression of CCL17, the ligand of CCR4, and CCL20 is increased, whereas CCL27 is decreased in the lesional skin of psoriatic patients ( Gudjonsson et al., 2010 ; Homey et al., 2000a ; Kim et al., 2014 ; Quaranta et al., 2014 ; Sahmatova et al., 2017 ).…”